back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-08-18 12:40 Tx date 2026-08-17 |
$AGN
Grey Matters Health Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+45,000 vol |
161,500 | |
| Filed 2026-08-18 12:39 Tx date 2026-08-17 |
$AGN
Grey Matters Health Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-45,000 vol |
0 | |
| Filed 2026-08-13 09:49 Tx date 2026-08-10 |
$AGN
Grey Matters Health Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+45,000 vol |
45,000 | |
| Filed 2026-08-13 09:37 Tx date 2026-08-10 |
$AGN
Grey Matters Health Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+45,000 vol |
||
| Filed 2026-08-10 17:18 Tx date 2026-04-21 |
$AGN
Grey Matters Health Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-184,500 vol |
20,500 | |
| Filed 2026-08-10 17:18 Tx date 2025-03-05 |
$AGN
Grey Matters Health Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+205,000 vol |
205,000 | |
| Filed 2026-08-10 17:17 Tx date 2025-01-06 |
$AGN
Grey Matters Health Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-40,000 vol |
0 | |
| Filed 2026-08-10 17:15 Tx date 2026-06-17 |
$AGN
Grey Matters Health Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+100,000 vol |
100,000 | |
| Filed 2026-08-10 17:14 Tx date 2026-06-17 |
$AGN
Grey Matters Health Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$40,000
+100,000 vol $0.40 each |
116,500 | |
| Filed 2026-08-10 17:14 Tx date 2026-04-21 |
$AGN
Grey Matters Health Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-156,680 vol |
16,500 | |
| Filed 2024-02-08 13:55 Tx date 2024-02-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+125,000 vol |
173,180 | |
| Filed 2024-02-08 13:55 Tx date 2024-02-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-125,000 vol |
0 | |
| Filed 2024-02-04 10:53 Tx date 2024-01-30 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+125,000 vol |
125,000 | |
| Filed 2024-01-04 15:46 Tx date 2024-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+26,668 vol |
48,180 | |
| Filed 2024-01-04 15:45 Tx date 2024-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-26,668 vol |
0 | |
| Filed 2023-03-19 20:32 Tx date 2023-03-14 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-13,332 vol |
26,668 | |
| Filed 2023-03-19 20:31 Tx date 2023-03-14 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+13,332 vol |
21,512 | |
| Filed 2023-03-14 13:01 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
37 - Stock split or consolidation
|
+30,000 vol |
40,000 | |
| Filed 2023-03-14 13:00 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+30,000 vol |
40,000 | |
| Filed 2023-03-14 12:58 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+6,135 vol |
8,180 |